Proposed Data Collections Submitted for Public Comment and Recommendations, 14400-14401 [2011-6107]

Download as PDF 14400 Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices Seleda Perryman, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2011–6078 Filed 3–15–11; 8:45 am] BILLING CODE 4150–30–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier: OS–0990–New] Agency Information Collection Request; 60-Day Public Comment Request Office on Women’s Health, Office of the Secretary, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed information collection request for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect AGENCY: of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your request, including your address, phone number, OMB number, and OS document identifier, to Sherette.funncoleman@hhs.gov, or call the Reports Clearance Office on (202) 690–6162. Written comments and recommendations for the proposed information collections must be directed to the OS Paperwork Clearance Officer Type of respondent Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Single Parent Caregivers ..... 1,000 1 18/60 300 Forms Single Parent Caregiver Survey Instrument Seleda Perryman, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2011–6086 Filed 3–15–11; 8:45 am] BILLING CODE 4150–33–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60-Day–11–11DD] jlentini on DSKJ8SOYB1PROD with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Carol E. Walker, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA VerDate Mar<15>2010 16:56 Mar 15, 2011 at the above e-mail address within 60days. Proposed Project: National Survey of Single Parent Caregivers—OMB No. 0990-NEW-OWH; HHS, Office on Women’s Health. Abstract: The National Survey of Single Parent Caregivers will measure the size, characteristics, and unmet needs of single parents providing care for an adult family member or friend. Single parent caregivers provide support services and financial assistance for two generations without the aid of a married partner. Survey results will be used to develop national estimates of the costs borne by single parent caregivers, their psychosocial burden, stress, and diminished social and leisure opportunities, and suggest policy options that mitigate the burden on single parent caregivers. The survey will be administered once under a one-year request, and will contact individuals using computer-assisted telephone interviewing (CATI) methods. Jkt 223001 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project: Raising Public Awareness for Deep Vein Thrombosis/ Pulmonary Embolism—NEW—National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Division of Blood Disorders, located within the National Center on Birth Defects and Developmental Disabilities, implements health promotion and wellness programs PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 designed to prevent secondary conditions in people with bleeding and clotting disorders. There are few public health problems as serious as deep vein thrombosis (DVT) and pulmonary embolism (PE), yet these conditions receive little attention. DVT/PE is an under diagnosed, serious, preventable medical condition that occurs when a blood clot forms in a deep vein. These clots usually develop in the lower leg, thigh, or pelvis, but they can also occur in the arm. In more than one third of people affected by DVT, clots can travel to the lungs and cause PE, a potentially fatal condition. The precise number of people affected by DVT/PE is unknown, but estimates range from 300,000 to 600,000 annually in the United States. DVT/PE is associated with substantial morbidity and mortality: One third of people with DVT/PE will have a recurrence within 10 years and one third of people die within 1 month of diagnosis. Among people who have had a DVT, one third will have long-term complications (postthrombotic syndrome), such as swelling, pain, discoloration, and scaling in the affected limb. In some cases, the symptoms can be so severe that a person can become disabled. More troubling, sudden death is the first symptom in E:\FR\FM\16MRN1.SGM 16MRN1 14401 Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices about one quarter of people who have a PE. The Division of Blood Disorders submitted questions to the 2007 HealthStyles survey to determine the public’s knowledge of DVT, its common symptoms, and risk factors. Although over 60% of respondents identified pain and swelling as symptoms, 60% did not identify tenderness (often the first sign of DVT) as a symptom. Only 38% of respondents knew that a DVT was a blood clot in a vein, and most could not identify common risk factors for DVT such as sitting for a long period of time (e.g., during air travel); having a leg or foot injury; having a family member who has had a DVT; taking birth control pills; or getting older; and certain groups could not identify risk factors that specifically applied to their risk. The results of this survey demonstrates the need for greater awareness of DVT, and its risk factors and the data show that there are many opportunities to develop audience specific messages that are age specific and culturally appropriate. Much of the morbidity and mortality associated with DVT/PE could be prevented with early and accurate diagnosis and management. DVT/PE is preventable. It is important for people to developed from insights emerging from this exploratory research phase. The Contractor will conduct eight (8) focus groups with nine (9) participants in each focus group during the second stage to test the message concepts and identify possible ways to present the messages. It is estimated that 144 respondents will have to be screened in order to recruit 72 focus group participants. The informed consent will take approximately 6 minutes to complete, for a total burden of 7 hours. The Contractor selected will work with CDC to identify and recruit focus group participants. Formative research participants will include adults (aged 25–64) who have been hospitalized in the last year and seniors (aged 65–80). Message testing participants will include adults (aged 25–64) who have been hospitalized in the last year and seniors (aged 65–80). Participants will be recruited to participate in one of sixteen in-person focus groups that will be conducted in the following cities: • Atlanta, Baltimore, Pittsburgh, and Tampa (formative research task), and • Atlanta, Baltimore, Pittsburgh, and Tampa (message testing task) There are no costs to the respondents other than their time. be able to recognize the signs and symptoms and know when to seek care and available treatment. Individuals, families, and their support communities can reduce their risk by understanding DVT/PE and its risk factors. DVT/PE affects people of all races and ages. Many of the acquired risks such as obesity, advanced age, air travel, chronic diseases, cancer, and hospitalization are increasing in the United States, and we can expect to see increasing numbers of people affected by DVT/PE. The CDC’s Division of Blood Disorders will conduct focus groups to develop messaging concepts that will be used in a public awareness campaign to build knowledge and awareness of DVT/ PE, increase recognition of the symptoms and risk factors for DVT/PE, and empower people to take action. The project will address these objectives in two stages: In the first stage the Contractor selected will conduct eight (8) formative focus groups with nine (9) participants in each focus group to explore consumer knowledge, attitudes, and beliefs (KABs) toward DVT. It is estimated that 144 respondents will have to be screened in order to recruit 72 focus group participants. Message concepts will be ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Average burden per response (in hours) Number responses per respondent Total burden hours Type of respondent Form name Seniors (65–80) ................................ Adults (25–64) recently hospitalized Formative research stage: Participant Screener and Recruitment Script. Message testing stage: Re-screener 144 1 5/60 12 144 1 9/60 22 Formative Research stage: Moderator’s Guide. Formative Research stage: Informed Consent. Message testing stage: Moderator’s Guide. Message testing stage: Informed Consent. ........................................................... 72 1 1.5 108 72 1 6/60 7 72 1 1.5 108 72 1 6/60 7 ........................ ........................ ........................ 264 Seniors (65–80) ................................ Adults (25–64) recently hospitalized Seniors (65–80) ................................ Adults (25–64) recently hospitalized Seniors (65–80) ................................ Adults (25–64) recently hospitalized Seniors (65–80) ................................ Adults (25–64) recently hospitalized Seniors (65–80) ................................ Adults (25–64) recently hospitalized Total ........................................... Dated: March 10, 2011. Carol E. Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES jlentini on DSKJ8SOYB1PROD with NOTICES [FR Doc. 2011–6107 Filed 3–15–11; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–18–P [30-Day–11–0338] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under VerDate Mar<15>2010 16:56 Mar 15, 2011 Jkt 223001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 76, Number 51 (Wednesday, March 16, 2011)]
[Notices]
[Pages 14400-14401]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-6107]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-11-11DD]

Proposed Data Collections Submitted for Public Comment and
Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Carol E. Walker, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project: Raising Public Awareness for Deep Vein
Thrombosis/Pulmonary Embolism--NEW--National Center on Birth Defects
and Developmental Disabilities (NCBDDD), Centers for Disease Control
and Prevention (CDC).

Background and Brief Description

The Division of Blood Disorders, located within the National Center
on Birth Defects and Developmental Disabilities, implements health
promotion and wellness programs designed to prevent secondary
conditions in people with bleeding and clotting disorders.
There are few public health problems as serious as deep vein
thrombosis (DVT) and pulmonary embolism (PE), yet these conditions
receive little attention. DVT/PE is an under diagnosed, serious,
preventable medical condition that occurs when a blood clot forms in a
deep vein. These clots usually develop in the lower leg, thigh, or
pelvis, but they can also occur in the arm. In more than one third of
people affected by DVT, clots can travel to the lungs and cause PE, a
potentially fatal condition.
The precise number of people affected by DVT/PE is unknown, but
estimates range from 300,000 to 600,000 annually in the United States.
DVT/PE is associated with substantial morbidity and mortality: One
third of people with DVT/PE will have a recurrence within 10 years and
one third of people die within 1 month of diagnosis. Among people who
have had a DVT, one third will have long-term complications (post-
thrombotic syndrome), such as swelling, pain, discoloration, and
scaling in the affected limb. In some cases, the symptoms can be so
severe that a person can become disabled. More troubling, sudden death
is the first symptom in

[[Page 14401]]

about one quarter of people who have a PE.
The Division of Blood Disorders submitted questions to the 2007
HealthStyles survey to determine the public's knowledge of DVT, its
common symptoms, and risk factors. Although over 60% of respondents
identified pain and swelling as symptoms, 60% did not identify
tenderness (often the first sign of DVT) as a symptom. Only 38% of
respondents knew that a DVT was a blood clot in a vein, and most could
not identify common risk factors for DVT such as sitting for a long
period of time (e.g., during air travel); having a leg or foot injury;
having a family member who has had a DVT; taking birth control pills;
or getting older; and certain groups could not identify risk factors
that specifically applied to their risk. The results of this survey
demonstrates the need for greater awareness of DVT, and its risk
factors and the data show that there are many opportunities to develop
audience specific messages that are age specific and culturally
appropriate.
Much of the morbidity and mortality associated with DVT/PE could be
prevented with early and accurate diagnosis and management. DVT/PE is
preventable. It is important for people to be able to recognize the
signs and symptoms and know when to seek care and available treatment.
Individuals, families, and their support communities can reduce their
risk by understanding DVT/PE and its risk factors. DVT/PE affects
people of all races and ages. Many of the acquired risks such as
obesity, advanced age, air travel, chronic diseases, cancer, and
hospitalization are increasing in the United States, and we can expect
to see increasing numbers of people affected by DVT/PE.
The CDC's Division of Blood Disorders will conduct focus groups to
develop messaging concepts that will be used in a public awareness
campaign to build knowledge and awareness of DVT/PE, increase
recognition of the symptoms and risk factors for DVT/PE, and empower
people to take action.
The project will address these objectives in two stages: In the
first stage the Contractor selected will conduct eight (8) formative
focus groups with nine (9) participants in each focus group to explore
consumer knowledge, attitudes, and beliefs (KABs) toward DVT. It is
estimated that 144 respondents will have to be screened in order to
recruit 72 focus group participants. Message concepts will be developed
from insights emerging from this exploratory research phase. The
Contractor will conduct eight (8) focus groups with nine (9)
participants in each focus group during the second stage to test the
message concepts and identify possible ways to present the messages. It
is estimated that 144 respondents will have to be screened in order to
recruit 72 focus group participants. The informed consent will take
approximately 6 minutes to complete, for a total burden of 7 hours.
The Contractor selected will work with CDC to identify and recruit
focus group participants. Formative research participants will include
adults (aged 25-64) who have been hospitalized in the last year and
seniors (aged 65-80). Message testing participants will include adults
(aged 25-64) who have been hospitalized in the last year and seniors
(aged 65-80). Participants will be recruited to participate in one of
sixteen in-person focus groups that will be conducted in the following
cities:
Atlanta, Baltimore, Pittsburgh, and Tampa (formative
research task), and
Atlanta, Baltimore, Pittsburgh, and Tampa (message testing
task)
There are no costs to the respondents other than their time.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Seniors (65-80)............... Formative 144 1 5/60 12
Adults (25-64) recently research stage:
hospitalized. Participant
Screener and
Recruitment
Script.
Seniors (65-80)............... Message testing 144 1 9/60 22
Adults (25-64) recently stage: Re-
hospitalized. screener.
Seniors (65-80)............... Formative 72 1 1.5 108
Adults (25-64) recently Research stage:
hospitalized. Moderator's
Guide.
Seniors (65-80)............... Formative 72 1 6/60 7
Adults (25-64) recently Research stage:
hospitalized. Informed
Consent.
Seniors (65-80)............... Message testing 72 1 1.5 108
Adults (25-64) recently stage:
hospitalized. Moderator's
Guide.
Seniors (65-80)............... Message testing 72 1 6/60 7
Adults (25-64) recently stage: Informed
hospitalized. Consent.
Total..................... ................ .............. .............. .............. 264
---------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------

Dated: March 10, 2011.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-6107 Filed 3-15-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.